| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $950.0K | $12.0M | $37.3M |
| YoY Revenue Growth % | -92.1% | -67.9% | — |
| Gross Profit | $594.0K | $2.7M | — |
| Gross Margin % | 62.5% | 22.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$157.1M | -$95.4M | -$212.0M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$167.3M | -$172.5M | -$265.3M |
| EBITDA (Normalized) | — | -$95.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$5.1M | $33.6M | -$138.0M |
| Capital Expenditures (CapEx) | — | $160.0K | — |
| Free Cash Flow (FCF) | -$5.1M | $33.4M | -$138.0M |
| FCF Margin % | -80.0% | 80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $4.1M | $148.0K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$111.8M | -$62.6M | — |